Biotech Stock Mailbag: Good Stocks Exist
Find out what stocks escape our biotech expert's wrath.
08:00AM 06/12/09
Biotech Stock Mailbag: HEB's Artful Dodging
Readers chime in on Hemispherx, Genxyme, ASCO, Cell Therapeutics and Cardiome.
07:59AM 06/05/09
Northfield Blood Substitute Rejected by FDA
The Food and Drug Administration refused to approve the human blood substitute, Polyheme, for use in trauma patients suffering from severe blood loss.
12:28AM 05/01/09
Northfield, Polyheme Not Long for This World
An FDA decision to not convene a panel of blood experts to review Northfield Labs' Polyheme is a signal the agency already has decided to reject the blood substitute for approval.
12:21AM 03/18/09
Ex-Biopure Exec Pleads Guilty To Faking Cancer
Former Biopure executive pleads guilty to lying about terminal cancer to avoid SEC complaint
02:09PM 03/11/09
Blood Sub or Not, Northfield's a Negative
With the odds stacked against Polyheme being approved, investors should think hard before chasing this stock.
06:05PM 01/22/09
Biotech Notebook: Progenics, Wyeth, Introgen
Projecting potential market share for newly approved Relistor; monitoring exec moves at Introgen; and more.
09:26AM 04/30/08
Feuerstein's Biotech-Stock Mailbag
Vertex's cystic fibrosis compound shows promise, but be cautious in your enthusiasm. Also, an update on the quest for blood substitutes.
12:01PM 03/29/08
Tracking the latest activist plays, and is 3Com poised for a comeback?
07:34AM 08/23/07
Northfield Botched Release of Safety Data
It's hard to believe the blood-substitute maker didn't know of the heart attack risks earlier.
12:04AM 08/07/07
The company's confidence in approval for its blood substitute disregards its own data.
12:10AM 06/20/07
Northfield Trounced After Data Mix-up
Data discrepancies will mean a reanalysis of a clinical trial. The stock sinks 55%.
05:59PM 12/19/06
As the Dow hits a new high, money manager Ken Fisher explains why stocks will keep rallying in '07.
05:42PM 12/15/06
Friday's Health Winners & Losers
Genta plunges as regulators say its cancer treatment is not approvable.
01:55PM 12/15/06



Connect with TheStreet